Compound 1337
Identifiers
- Canonical SMILES:
CC(C)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C
- IUPAC name:
(2S)-1-[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]-N-(2-methylpropyl)pyrrolidine-2-carboxamide
- InChi:
InChI=1S/C17H32N4O3/c1-10(2)9-19-16(23)13-7-6-8-21(13)17(24)14(11(3)4)20-15(22)12(5)18/h10-14H,6-9,18H2,1-5H3,(H,19,23)(H,20,22)/t12-,13-,14-/m0/s1
- InChiKey:
TWHNXFZXAMDVAL-IHRRRGAJSA-N
External links
![]() 11450670 |
![]() CHEMBL180306 |
![]() 9625522 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
XIAP / Smac | 4.87 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 340.25 g/mol | |||
HBA | 7 | |||
HBD | 4 | |||
HBA + HBD | 11 | |||
AlogP | 0.17 | |||
TPSA | 104.53 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.9362 | Cyclo(prolylglycyl) | DB04541 | |
0.8958 | acetylleucyl-leucyl-norleucinal | DB07558 | |
0.7797 | Rapastinel | DB11801 | |
0.7797 | Dusquetide | DB11879 | |
0.7708 | Pramiracetam | DB13247 | |
0.7667 | Larazotide | DB05645 | |
0.7647 | Brivaracetam | DB05541 | |
0.7500 | Verpacamide A | DB04433 | |
0.7377 | NNZ-2591 | DB15601 | |
0.7292 | Valrocemide | DB06657 | |
0.7097 | Sinapultide | DB11332 | |
0.7083 | Etiracetam | DB11868 | |
0.7083 | Levetiracetam | DB01202 | |
0.7077 | Glypromate | DB05633 | |
0.7077 | Trofinetide | DB06045 |